BROWN MORGAN R — SEC insider filings

SEC reporting owner CIK 1266062. 16 insider filings on record with FilingPulse; latest filed 2026-10-21.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2020-12-08 to 2026-10-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Lipocine Inc. (LPCN)Chief Financial Officer3—2 legs · 25,687 sh · $38,4148
Clene Inc. (CLNN)Chief Financial Officer13——13

Insider filings — BROWN MORGAN R

FiledFormIssuerReported transactionsSource
2026-10-214Clene Inc. (CLNN)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2026-06-154Clene Inc. (CLNN)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2026-01-234Clene Inc. (CLNN)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2025-09-304/AClene Inc. (CLNN)Holdings only — no transactions reportedEDGAR
2025-09-294Clene Inc. (CLNN)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2025-09-194Clene Inc. (CLNN)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2025-02-254Clene Inc. (CLNN)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2024-08-194Clene Inc. (CLNN)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2024-06-114Clene Inc. (CLNN)Grant/award (A): 400,000 (derivative) @ $0 · Grant/award (A): 600,000 (derivative) @ $0EDGAR
2023-07-034Clene Inc. (CLNN)Grant/award (A): 400,000 (derivative) @ $0EDGAR
2023-02-214Clene Inc. (CLNN)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2022-11-074Clene Inc. (CLNN)Grant/award (A): 300,000 (derivative) @ $0EDGAR
2022-02-034Clene Inc. (CLNN)Grant/award (A): 250,000 (derivative) @ $0EDGAR
2021-12-084Lipocine Inc. (LPCN)Grant/award (A): 176,000 (derivative) @ $1.12EDGAR
2020-12-174Lipocine Inc. (LPCN)Option exercise (M): 28,125 @ $0 · Sale (S): 8,437 @ $1.35 · Grant/award (A): 160,000 (derivative) @ $1.37 · Option exercise (M): 28,125 (derivative) @ $0EDGAR
2020-12-084Lipocine Inc. (LPCN)Option exercise (M): 57,500 @ $0 · Sale (S): 17,250 @ $1.57 · Option exercise (M): 70,754 @ $0 · Option exercise (M): 57,500 (derivative) @ $0 · Option exercise (M): 70,754 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1266062 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs